Table Graph
      published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 outpatients - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsThomas (vitamin c only), 2021 (REV) 0.47 [0.02; 14.49] 0.47[0.02; 14.49]Thomas (vitamin c only), 2021 (REV)10%98NAnot evaluable clinical improvementdetailed resultsThomas (vitamin c only), 2021 (REV) 0.32 [0.06; 1.66] 0.32[0.06; 1.66]Thomas (vitamin c only), 2021 (REV)10%98NAnot evaluable clinical improvement (7-day)detailed resultsThomas (vitamin c only), 2021 (REV) 0.32 [0.06; 1.66] 0.32[0.06; 1.66]Thomas (vitamin c only), 2021 (REV)10%98NAnot evaluable hospitalizationdetailed resultsThomas (vitamin c only), 2021 (REV) 1.47 [0.23; 9.20] 1.47[0.23; 9.20]Thomas (vitamin c only), 2021 (REV)10%98NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-06-06 11:07 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 97 - treatments: 651 - roots T: 651

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons